What does chronic cervicitis cin1 mean?

Chronic cervicitis CIN1 refers to cervical intraepithelial neoplasia grade 1, which is the mildest form of cervical precancerous lesions and is usually caused by high-risk human papillomavirus infection.

1. Cause mechanism

Chronic cervicitis CIN1 is mainly related to persistent infection with high-risk HPV viruses, especially HPV16 and HPV18. The virus causes mild dysplasia of cervical squamous epithelial cells, and the lesions are limited to the lower 1/3 of the epithelium. Other triggers include multiple childbirth injuries, long-term chronic inflammatory stimulation, or an immunocompromised state. Patients may experience symptoms such as contact bleeding and increased leucorrhea, but about 60% of CIN1 can resolve on its own.

2. Pathological characteristics

Pathological examination showed proliferation of cervical squamous epithelial basal cells, slightly enlarged and deeply stained nuclei, mitotic figures limited to the subepithelial 1/3 area, and normal cell polarity. Compared with CIN2/3 grade, CIN1 cell atypia is milder and the scope of atypical hyperplasia is smaller. Colposcopy may reveal changes such as acetic acid white epithelium and punctate blood vessels, but there is no obvious mosaic or thick blood vessel pattern.

3. Diagnostic methods

The diagnosis requires a combination of TCT cervical cytology, HPV typing testing and colposcopy biopsy. TCT reports may show low-grade squamous intraepithelial lesions, and HPV tests are mostly positive for high-risk types. Colposcopy localized biopsy is the diagnostic gold standard, which can clarify the extent of the disease and rule out higher-grade lesions. If necessary, cervical curettage is performed to evaluate the condition within the cervical canal.

4. Treatment principles

Most CIN1 recommend follow-up observation and recheck TCT and HPV every 6-12 months. Those with persistent infection or obvious symptoms may choose physical therapy, such as cryotherapy, laser or electrocautery. For drug treatment, topical medications such as recombinant human interferon α2b suppository and Baofukang suppository can be selected. To avoid overtreatment, management of pregnant patients is often postponed until the postpartum period.

5. Prognosis management

The probability of CIN1 progressing to invasive cancer is less than 1%, but the risk of persistent HPV infection needs to be alerted. It is recommended to vaccinate against HPV to prevent reinfection and improve lifestyle to enhance immunity. When lesions escalate, HPV remains positive, or symptoms worsen during follow-up, colposcopy evaluation is required in a timely manner. Patients over 30 years old are recommended to continue joint screening for at least 10 years.

Patients with chronic cervicitis CIN1 should maintain a regular schedule, appropriately supplement antioxidants such as selenium and vitamin C, and avoid frequent vaginal douching. Using condoms during sex can reduce the risk of HPV transmission, and you should have a gynecological examination at least once a year. If you experience abnormal vaginal bleeding or increased discharge, you need to seek medical attention promptly. Women aged 30-45 are recommended to undergo combined HPV and TCT screening every 3 years.